Oct 30, 2023ATM Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityJERUSALEM, October 30, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Oct 24, 2023Former U.S. Commissioner of FDA Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardJERUSALEM, October 24, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Sep 14, 2023Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Hadassah Medical CenterJERUSALEM, Sept. 14, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Aug 29, 2023Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April – – 89% CR,...
Aug 24, 2023Alpha Tau Medical to Participate in September Investor ConferencesJERUSALEM, August 24, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...